INTRODUCTION: Ubiquinone (UQ) is a redox active lipid that transfers electrons from complex I or II to complex III in the electron transport chain (ETC). The long-lived Caenorhabditis elegans mutant clk-1 is unable to synthesize its native ubiquinone, and accumulates high amounts of its precursor, 5-demethoxyubiquinone-9 (DMQ(9)). In clk-1, complexes I-III activity is inhibited while complexes II-III activity is normal. We asked whether the complexes I-III defect in clk-1 was caused by: (1) a defect in the ETC; (2) an inhibitory effect of DMQ(9); or (3) a decreased amount of ubiquinone. METHODS: We extracted the endogenous quinones from wildtype (N2) and clk-1 mitochondria, replenished them with exogenous ubiquinones, and measured ETC activities. RESULTS: Replenishment of extracted mutant and wildtype mitochondria resulted in equal enzymatic activities for complexes I-III and II-III ETC assays. Blue native gels showed that supercomplex formation was indistinguishable between clk-1 and N2. The addition of a pentane extract from clk-1 mitochondria containing DMQ(9) to wildtype mitochondria specifically inhibited complexes I-III activity. UQ in clk-1 mitochondria was oxidized compared to N2. DISCUSSION: Our results show that no measurable intrinsic ETC defect exists in clk-1 mitochondria. The data indicate that DMQ(9) specifically inhibits electron transfer from complex I to ubiquinone.
INTRODUCTION:Ubiquinone (UQ) is a redox active lipid that transfers electrons from complex I or II to complex III in the electron transport chain (ETC). The long-lived Caenorhabditis elegans mutant clk-1 is unable to synthesize its native ubiquinone, and accumulates high amounts of its precursor, 5-demethoxyubiquinone-9 (DMQ(9)). In clk-1, complexes I-III activity is inhibited while complexes II-III activity is normal. We asked whether the complexes I-III defect in clk-1 was caused by: (1) a defect in the ETC; (2) an inhibitory effect of DMQ(9); or (3) a decreased amount of ubiquinone. METHODS: We extracted the endogenous quinones from wildtype (N2) and clk-1 mitochondria, replenished them with exogenous ubiquinones, and measured ETC activities. RESULTS: Replenishment of extracted mutant and wildtype mitochondria resulted in equal enzymatic activities for complexes I-III and II-III ETC assays. Blue native gels showed that supercomplex formation was indistinguishable between clk-1 and N2. The addition of a pentane extract from clk-1 mitochondria containing DMQ(9) to wildtype mitochondria specifically inhibited complexes I-III activity. UQ in clk-1 mitochondria was oxidized compared to N2. DISCUSSION: Our results show that no measurable intrinsic ETC defect exists in clk-1 mitochondria. The data indicate that DMQ(9) specifically inhibits electron transfer from complex I to ubiquinone.
Authors: Elisa I Glover; Joan Martin; Amy Maher; Rebecca E Thornhill; Gerald R Moran; Mark A Tarnopolsky Journal: Muscle Nerve Date: 2010-11 Impact factor: 3.217
Authors: Sarah L Molyneux; Christopher M Florkowski; A Mark Richards; Michael Lever; Joanna M Young; Peter M George Journal: N Z Med J Date: 2009-10-30
Authors: Ryan Doonan; Joshua J McElwee; Filip Matthijssens; Glenda A Walker; Koen Houthoofd; Patricia Back; Andrea Matscheski; Jacques R Vanfleteren; David Gems Journal: Genes Dev Date: 2008-12-01 Impact factor: 11.361
Authors: Marni J Falk; Julie R Rosenjack; Erzsebet Polyak; Wichit Suthammarak; Zhongxue Chen; Phil G Morgan; Margaret M Sedensky Journal: PLoS One Date: 2009-08-12 Impact factor: 3.240
Authors: Hyo-Seok Na; Nicole L Brockway; Katherine R Gentry; Elyce Opheim; Margaret M Sedensky; Philip G Morgan Journal: Neurotoxicol Teratol Date: 2016-10-29 Impact factor: 3.763
Authors: Christopher M Allan; Shauna Hill; Susan Morvaridi; Ryoichi Saiki; Jarrett S Johnson; Wei-Siang Liau; Kathleen Hirano; Tadashi Kawashima; Ziming Ji; Joseph A Loo; Jennifer N Shepherd; Catherine F Clarke Journal: Biochim Biophys Acta Date: 2012-12-25